Clinical Trials Logo

Granulomatosis With Polyangiitis clinical trials

View clinical trials related to Granulomatosis With Polyangiitis.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06230354 Enrolling by invitation - Clinical trials for EGPA - Eosinophilic Granulomatosis With Polyangiitis

Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis

RACEMATE
Start date: May 2024
Phase: Phase 2
Study type: Interventional

RACEMATE is a phase 2b, multicentre, randomised, double-blinded, placebo-controlled study designed to explore the efficacy and mechanism of action of tezepelumab in adults with eosinophilic granulomatosis with polyangiitis (EGPA).